Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia
The drug efflux pump ABCB1 (ATP binding cassette subfamily B member 1) confers chemotherapy resistance in acute myeloid leukemia (AML). We recently identified an ABCB1 enhancer that is activated in response to a range of cellular stressors, including anthracycline chemotherapy. Stress drives increas...
Main Authors: | Mark S. Williams, Tim C. P. Somervaille |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-03-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2019.1705730 |
Similar Items
-
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
by: Thomas Boyer, et al.
Published: (2019-09-01) -
Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia
by: Luz K. Yunis, et al.
Published: (2023-03-01) -
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
by: Carolina Alarcón-Payer, et al.
Published: (2022-09-01) -
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
by: Antonio Piccolomo, et al.
Published: (2020-09-01) -
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival
by: Lauren Pommert, et al.
Published: (2022-01-01)